The FDA issued a drug safety communication regarding rare but severe pruritus associated with discontinuation of long-term use of cetirizine or levocetirizine.
Michelle Kaplun, PharmD Candidate
Advertisement
Articles by Michelle Kaplun, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis On the Rise in the United States, Exceeding 450 Cases
2
FDA Approves Atacicept-vymj to Reduce Proteinuria in IgA Nephropathy
3
USP's Matt Christian: Why Drug Shortages Are Becoming Longer—and Harder to Solve
4
Study Links Several Progestogen Contraceptives to Rare Meningioma Risk, Reinforcing Individualized Patient Counseling
5